Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Repligen Corporation (RGEN) Guidance & Earnings Results

On 2026-07-28 Repligen Corporation raised guidance: "FY26 organic revenue growth guidance raised to 10.5%-13.5% from prior; FY26 adjusted EPS raised to $2.03-$2.09; FY26 total reported revenue $813M-$835M; FY26 gross margin 53.7%-54.2%; FY26 adjusted operating margin…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RGENRepligen CorporationFollow RGEN — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
10.0B
P/E TTM
242.4
Dividend yield
—
52-week
—
Next earnings
27 Oct, in 3 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
28 Jul 26RaisedFY26 organic revenue growth guidance raised to 10.5%-13.5% from prior; FY26 adjusted EPS raised to $2.03-$2.09; FY26 total reported revenue $813M-$835M; FY26 gross margin 53.7%-54.2%; FY26 adjusted operating margin 15.7%-16.0%; FY26 adjusted EBITDA margin 20.6%-21.0%; FY26 other income ~$19M; FY26 tax rate ~22%; FY26 net income $115.5M-$118.5M · full year
5 May 26RaisedAdjusted EPS raised to $1.97-$2.05 from prior range; revenue guidance reiterated at $803M-$833M · full year
24 Feb 26RaisedFY2026 revenue guidance $810M-$840M (10-14% reported growth, 9-13% organic); adjusted operating margin 15.1-15.5% (+150bps at midpoint) · full year
28 Oct 25RaisedRevenue guidance raised to $729-737M from prior range · full year
29 Jul 25RaisedFY2025 revenue raised to $715M-$735M from prior; organic non-COVID growth 12.5%-15.5%; adjusted gross margin 52%-53%; adjusted operating margin 13.5%-14.5%; adjusted EBITDA margin 19.5%-20.5%; adjusted EPS $1.65-$1.72 · full year

Repligen Corporation — questions

What guidance did Repligen Corporation give?
On 2026-07-28: "FY26 organic revenue growth guidance raised to 10.5%-13.5% from prior; FY26 adjusted EPS raised to $2.03-$2.09; FY26 total reported revenue $813M-$835M; FY26 gross margin 53.7%-54.2%; FY26 adjusted operating margin 15.7%-16.0%; FY26 adjusted EBITDA margin 20.6%-21.0%; FY26 other income ~$19M; FY26 t"
When does Repligen Corporation report earnings?
Repligen Corporation's next earnings report is expected on 2026-10-27.

Every figure on this page comes from Repligen Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.